What is LOPJLB’s current signal on HLVX?

LOPJLB’s latest quantitative signal on HilleVax, Inc. (HLVX) is BUY in a BULL regime. Signals are updated daily.

What market regime is HLVX in?

HilleVax, Inc. (HLVX) is currently classified in the BULL HMM market regime on LOPJLB.

What does HilleVax, Inc. (HLVX) do?

HilleVax, Inc. is a clinical-stage biopharmaceutical enterprise specializing in the creation and market introduction of innovative vaccines. The company's lead investigational product is HIL-214, a vaccine candidate utilizing virus-like particles, which aims to prevent moderate-to-severe acute gastroenteritis resulting from norovirus infections. Its corporate headquarters are located in Boston,…

Where is HilleVax, Inc. based / listed?

HilleVax, Inc. is based in US, listed on NASDAQ.

HilleVax, Inc. (HLVX) Stock · BUY · BULL

Key stats

Market cap: $105M
Avg volume: 718.7K

Beta: 0.77
P/E (TTM): -9.09

1W: +0.00%
YTD: -1.42%

vs SPY 1W: +1.19%
vs SPY YTD: -13.17%

Sector peers

Same-sector names ranked by LOPJLB quality proximity · Healthcare

Industry peers

FMP comparable companies · ranked by market cap

TRMLTourmaline Bio, Inc.$1.2B$47.98

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

HilleVax, Inc. (HLVX)

Key stats

Sector peers

Industry peers

Prediction markets

EARNINGS HISTORY

Company news